Redwood Investments’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-90,259
Closed -$11.2M 117
2023
Q1
$11.2M Buy
90,259
+2,719
+3% +$373K 1.44% 29
2022
Q4
$13.2M Buy
87,540
+33,294
+61% +$5.12M 1.76% 21
2022
Q3
$7.32M Buy
54,246
+100
+0.2% +$15.3K 0.98% 45
2022
Q2
$8.07M Buy
54,146
+15,212
+39% +$2.32M 0.9% 47
2022
Q1
$6.64M Buy
38,934
+13,145
+51% +$2.21M 0.63% 62
2021
Q4
$6.65M Sell
25,789
-18
-0.1% -$4.93K 0.52% 65
2021
Q3
$7.04M Sell
25,807
-525
-2% -$167K 0.59% 60
2021
Q2
$5.89M Sell
26,332
-45,280
-63% -$8.54M 0.48% 67
2021
Q1
$7.82M Sell
71,612
-10,634
-13% -$1.13M 0.69% 54
2020
Q4
$6.71M Buy
+82,246
New +$8.07M 0.57% 60

Other funds holding BNTX

Redwood Investments's BNTX Position: Q2 2023 in Review

Redwood Investments sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 90,259 shares — an estimated $11.2M sold.

Redwood Investments first reported a position in BNTX in Q4 2020 and held it in 10 quarters. The position peaked at $13.2M in Q4 2022. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

  • Redwood Investments reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
  • Redwood Investments sold 90,259 BioNTech shares in Q2 2023, an estimated $11.2M.
  • Redwood Investments first reported a position in BioNTech in Q4 2020 and held it in 10 quarters.
  • Redwood Investments's BioNTech position peaked at $13.2M in Q4 2022.
  • 253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on Redwood Investments's 13F filing for Q2 2023, filed 24 Jul 2023.